IL10 and periodontitis: Although this anti-inflammatory effect is suggested with β-glucan supplementation, the opposite is seen when MOS is administered producing significantly lower expression of IL-10 relative to the experimental periodontitis model, questioning the key differences between certain sub-cellular structures of prebiotics and their use as an anti-inflammatory cytokine modulator (35).